| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $157M | — | $156M | — | 0.1% |
| Op. Income | $75M | — | $77M | — | -2.7% |
| Gross Margin | 53.6% | — | 55.1% | — | -1.5pp |
| Net Margin | 39.4% | — | 33.0% | — | 6.4pp |
| EPS (Diluted) | $1.69 | — | $1.05 | — | 61.0% |
| Free Cash Flow | $0 | — | $92M | — | -100.0% |
| Item | Amount |
|---|---|
| REVENUE | $157M |
| Cost of Revenue | $73M |
| GROSS PROFIT | $84M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $9M |
| Other Expenses | $0 |
| Operating Expenses | $9M |
| Cost & Expenses | $81M |
| OPERATING INCOME | $75M |
| Interest Income | $0 |
| Interest Expense | $20M |
| Other Income/Expenses | -$14M |
| INCOME BEFORE TAX | $62M |
| Income Tax Expense | $0 |
| Net Income from Continuing Ops | $62M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $62M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $62M |
| D&A | $32M |
| EBIT | $75M |
| EBITDA | $108M |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| REVENUE | $157M |
| Cost of Revenue | $73M |
| GROSS PROFIT | $84M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $9M |
| Other Expenses | $0 |
| Operating Expenses | $9M |
| Cost & Expenses | $81M |
| OPERATING INCOME | $75M |
| Interest Income | $0 |
| Interest Expense | $20M |
| Other Income/Expenses | -$14M |
| INCOME BEFORE TAX | $62M |
| Income Tax Expense | $0 |
| Net Income from Continuing Ops | $62M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $62M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $62M |
| D&A | $32M |
| EBIT | $75M |
| EBITDA | $108M |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| Net Income | $62M |
| Depreciation & Amortization | $32M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $3M |
| Change in Working Capital | -$6M |
| OPERATING CASH FLOW | $90M |
| Capital Expenditure | -$90M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | $0 |
| Net Debt Issuance | -$44M |
| Common Stock Repurchased | -$1M |
| Common Dividends Paid | -$17M |
| Other Financing Activities | $0 |
| NET CASH FROM FINANCING | -$117M |
| FREE CASH FLOW | $0 |
| Net Change in Cash | -$27M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $41M |
| Short-Term Investments | $0 |
| Net Receivables | $0 |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $41M |
| PP&E (Net) | $733M |
| Goodwill | $0 |
| Intangible Assets | $0 |
| Long-Term Investments | $3M |
| Tax Assets | $0 |
| Other Non-Current Assets | $9M |
| TOTAL NON-CURRENT ASSETS | $745M |
| TOTAL ASSETS | $786M |
| Account Payables | $0 |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | $0 |
| TOTAL CURRENT LIABILITIES | $0 |
| Long-Term Debt | $277M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | -$277M |
| TOTAL NON-CURRENT LIABILITIES | $0 |
| TOTAL LIABILITIES | $313M |
| Common Stock | $400M |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $0 |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $0 |
| Other Equity | -$180.0K |
| TOTAL STOCKHOLDERS' EQUITY | $473M |
| Minority Interest | $0 |
| TOTAL EQUITY | $473M |
| TOTAL LIABILITIES & EQUITY | $786M |
| Total Debt | $277M |
| Net Debt | $236M |
